Also trades as: 6127.HK (HKSE) · $vol 26M
603127.SS SHH
Joinn Laboratories(China)Co.,Ltd.
1W: +6.9%
1M: +6.1%
3M: +24.4%
YTD: +32.1%
1Y: +63.4%
3Y: +77.2%
5Y: -24.2%
¥49.30 ($7.35)
+4.48 (+10.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Income Trends
Revenue
$2.0B
-15.1% ▼
5Y CAGR: +25.8%
Gross Profit
$521M
-46.9% ▼
5Y CAGR: +9.6%
Operating Income
$104M
-79.4% ▼
5Y CAGR: -13.5%
Net Income
$74M
-81.3% ▼
5Y CAGR: -16.9%
EPS (Diluted)
$0.10
-81.1% ▼
5Y CAGR: -19.9%
EBITDA
$180M
-73.5% ▼
5Y CAGR: -3.5%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $1.1B | $1.5B | $2.3B | $2.4B | $2.0B |
| YoY Growth | +68.3% | +41.0% | +49.5% | +4.8% | -15.1% |
| Cost of Revenue | $525M | $779M | $1.2B | $1.4B | $1.5B |
| Gross Profit | $551M | $738M | $1.1B | $982M | $521M |
| Gross Margin | 51.2% | 48.6% | 47.7% | 41.3% | 25.8% |
| R&D Expenses | $51M | $48M | $78M | $97M | $93M |
| SG&A Expenses | $222M | $272M | $318M | $305M | $317M |
| Operating Expenses | $190M | $95M | -$165M | $474M | $416M |
| Operating Income | $361M | $643M | $1.2B | $507M | $104M |
| Operating Margin | 33.6% | 42.4% | 55.0% | 21.3% | 5.2% |
| Interest Expense | $1M | $4M | $4M | $4M | $326K |
| Income Before Tax | $361M | $642M | $1.2B | $507M | $104M |
| Tax Expense | $47M | $86M | $167M | $115M | $34M |
| Net Income | $315M | $557M | $1.1B | $397M | $74M |
| Net Margin | 29.3% | 36.8% | 47.4% | 16.7% | 3.7% |
| EPS (Diluted) | $0.51 | $0.77 | $1.43 | $0.53 | $0.10 |
| EBITDA | $342M | $490M | $803M | $677M | $180M |
| Shares Outstanding | 622M | 728M | 750M | 749M | 741M |